Industry invitation
ECNP Congresses are Europe’s showcase for the future of CNS treatments
The mission of the ECNP Congress is to bring together under one roof all the many pieces that go to make up the CNS treatment puzzle – from the lab all the way to the pharmacy and clinic.
The bridge between basic science and real-world treatment is fundamental and the central organising principle of the ECNP Congress.
ECNP would therefore like to invite companies and organisations involved in clinical and pre-clinical research, diagnosis and treatment of disorders of the brain to contribute to the congress’s educational function, by allowing participants to gain access to your high-quality information and advice, services, products and literature.
We welcome participation in a variety of ways. We have several opportunities for companies at different price levels:
AIFA Regulations
AIFA (Italian Drug Agency) is the national authority responsible for drugs regulation in Italy. Any pharmaceutical company supporting or participating in a congress in Italy, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 — art.124). The official appointed Italian agency for AIFA authorisation is AIM Group International - AIM Education S.r.l.
The request of authorisation must be submitted within 60 days before the starting date of the event. Non-Italian pharmaceutical companies are advised to contact the Official Italian Agency appointed (AIM Group International - AIM Education S.r.l.) before 25 March 2024. See more details in the ECNP Industry Guidelines at item 3. AIFA Procedure.
Industry invitation flyer
